Revenio
Update in progressREG1V.HE (Helsinki)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Revenio Group Oyj provides ophthalmology devices and software for glaucoma, macular degeneration, and diabetic retinopathy diagnosis in Finland, the U.S., and globally. Its products include iCare tonometers (IC100, ST500, IC200, HOME2, TONOVET Pro, TONOVET Plus), iCare sensors, and imaging devices (EIDON, DRSplus, COMPASS). It also offers ILLUME AI screening software, CLINIC cloud for IOP data, and the Oculo care platform for telehealth and analytics. Based in Vantaa, founded 2001.
Company score
- Sentiment
- 0.32
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.12
- Governance
- 0.17
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.07
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.20
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!